Search
Relmada Therapeutics Inc
RLMDAdd to Watchlist
6.570USD
+0.200+3.14%
Close 06/16, 16:00（ET）Quotes delayed by 15 min
687.03MMarket Cap
LossP/E TTM
Relmada Therapeutics Inc's Company Valuation
Currency: USD Updated: 2026-06-16The current valuation score of Relmada Therapeutics Inc is 7.88, ranking 190 out of 388 in the Biotechnology & Medical Research industry. Its current P/E ratio is -5.98, which is -98.39% below the recent high of -0.10 and -14.35% above the recent low of -6.83.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.
